WavelinQ™ EndoAVF System is designed to create an endovascular AV fistula (endoAVF) for hemodialysis access in patients who have chronic kidney disease and need dialysis, using a completely endovascular approach in vessels that are not traditionally used during open surgery. Patients must meet certain anatomical characteristics that support ...Search for BD products by name, type or SKU number. Our Solutions. BD serves and supports our customers with full offerings beyond our individual products, enabling integrated solutions across healthcare systems to comprehensively improve care and lower costs.Business Description. Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units.Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment ...1 day ago · See the latest Becton Dickinson & Co stock price (NYSE:BDX), related news, ... Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles ... Analyst Report: Becton, Dickinson and Company Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and...BD Pyxis™ IV Prep. Intercept errors, reduce waste and optimize IV workflows BD Pyxis™ IV Prep is a comprehensive, gravimetric-based IV workflow management system that helps deliver safe and efficient medication compounding. BD Pyxis™ MedBank™. MedBank solutions focus on automating medication inventory management processes to help ...May 25, 2011 · The district court granted summary judgment of noninfringement of all asserted claims in the 164 and 745 patents. Therasense, Inc. v. Becton, Dickinson Co., 560 F.Supp.2d 835, 854, 880 (N.D.Cal. 2008). The district court also found nearly all of the asserted claims of the 745 patent invalid due to anticipation. SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. Designed to hold both insulin syringes and pen needles,* the BD home sharps container is a leak-proof and puncture-resistant container for safe, convenient disposal of used sharps.Nov 30, 2022 · Facility Will Add 500 New Jobs Over the Next Two Years. TIJUANA, Baja California, Mexico (Nov. 30, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was joined by government officials from Mexico and Baja California to inaugurate a new $38.6 million manufacturing facility in Tijuana ... Analyst Report: Becton, Dickinson and Company Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and...* The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 ...Sep 1, 2023 · Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (70.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (22.2%): automated systems for blood testing, mycobacteria detection ... Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive.About us. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The...Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive.Welcome to the electronic Instructions for Use (eIFU) website. From this site you can view and print eIFUs and Patient Information Leaflets (PILs) for many BD products. Consult the current Instructions for Use or Patient Information Leaflet approved for your specific country. BD products availability are subject to local country regulatory and ...SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected] Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive.Apple Inc. Common Stock. $180.07 -0.12 -0.07%. Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs ... 8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events.Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (70.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (22.2%): automated systems for blood testing, mycobacteria detection ...Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used ...Jul 24, 2023 · Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive. Franklin Lakes, NJ 07417. Company News. BD Statement on COVID-19 (Coronavirus) ... Unless otherwise noted, BD, the BD Logo and all other trademarks are property of Becton, Dickinson and ...* The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 ... Aug 3, 2023 · Operator. Hello, and welcome to BD’s Third Fiscal Quarter of 2023 Earnings Call. At the request of BD, today’s call is being recorded. And will be available for replay on BD’s Investor ... Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used ...As one of the largest global medical technology companies in the world, BD is deploying its capabilities, expertise and scale to address critical health needs related to coronavirus – from diagnostic offerings to identify COVID-19, to real-time informatics and electronic surveillance technology and to essential medical devices that support ... Becton, Dickinson & Co. is a medical technology Co. The company was founded in the year 1897 and is headquartered in Franklin Lakes, NJ. The firm is associated with the development, and sale of medical supplies of devices, and laboratory equipment used by healthcare institutions, the pharmaceutical industry, clinical laboratory physicians, life ... Welcome to the electronic Instructions for Use (eIFU) website. From this site you can view and print eIFUs and Patient Information Leaflets (PILs) for many BD products. Consult the current Instructions for Use or Patient Information Leaflet approved for your specific country. BD products availability are subject to local country regulatory and ...Nov 30, 2022 · Facility Will Add 500 New Jobs Over the Next Two Years. TIJUANA, Baja California, Mexico (Nov. 30, 2022) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was joined by government officials from Mexico and Baja California to inaugurate a new $38.6 million manufacturing facility in Tijuana ... Search for BD products by name, type or SKU number. Our Solutions. BD serves and supports our customers with full offerings beyond our individual products, enabling integrated solutions across healthcare systems to comprehensively improve care and lower costs.The company was founded in 1897 by two salesmen, Maxwell W. Becton and Fairleigh S. Dickinson, as a partnership first to sell medical thermometers and syringes (imported from Europe) and then to manufacture them. Expansion into new product lines in the early years came via acquisitions. Becton Dickinson India Private Limited (“BD”) does not run any investment schemes or solicit monies from general public. We have neither authorized any individual or legal entity to either collect money or arrive at any monetary arrangement for or on behalf of BD. BD is not in any way connected to the actions of any such persons.Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive. The BD Physioject™ Disposable Autoinjector 1 mL is a commercially proven, easy-to-use, button-activated, disposable autoinjector for the treatment of chronic diseases. 2,6,7. The BD Physioject™ Disposable Autoinjector 1 mL combined with BD Hypak™ for Biotech Glass Prefillable Syringes supports dose accuracy and enables the delivery of a ... 8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events. BD™ Diabetes Care App. BD ™ Diabetes Care App is the smarter, simpler approach to diabetes management. The BD ™ Diabetes Care App offers data logging and educational support, both of which are recommended by the ADA to encourage a healthy lifestyle. 5. Available on Apple App Store and Google Play. Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used ...Jul 18, 2022 · FRANKLIN LAKES, N.J., July 18, 2022 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce ... SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. The company was founded in 1897 by two salesmen, Maxwell W. Becton and Fairleigh S. Dickinson, as a partnership first to sell medical thermometers and syringes (imported from Europe) and then to manufacture them. Expansion into new product lines in the early years came via acquisitions. BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo...Becton, Dickinson and Company is a global medical technology company. The Company is engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment ...In 1897, Maxwell Becton and Fairleigh Dickinson founded Becton, Dickinson and Company with a vision to improve outcomes for patients. With more than a century of experience and our global reach, BD leads in patient and healthcare worker safety and the technologies that enable medical research and clinical laboratories. BD annual reports ... Search Tips: Click on the All tab to broaden your search across all BD.com content. Check the Knowledge Center for literature, case studies, events, or other documents. Explore our Products and Solutions. Search for related topics of interest using the search bar above, then try modifying your search using the filters at left. Tom Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company). Polen leads the $20 billion global medical technology company headquartered in Franklin Lakes, NJ, and works alongside 75,000+ BD associates who are making an impact and fulfilling the company’s purpose of advancing the world of health ™. Polen is focused on ... Inclusion, Diversity & Equity. Our leadership is committed to making BD the best possible place for talented people to work by driving inclusion and diversity as a cultural and strategic imperative across the company. Our associates come from all backgrounds, races, ages, colors, creeds, religions, genders, and orientations, and we are better ...As one of the largest global medical technology companies in the world, BD is deploying its capabilities, expertise and scale to address critical health needs related to coronavirus – from diagnostic offerings to identify COVID-19, to real-time informatics and electronic surveillance technology and to essential medical devices that support ...Dec 29, 2017 · PR Newswire. FRANKLIN LAKES, N.J., Dec. 29, 2017 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has completed the acquisition of C. R. Bard, Inc. (NYSE: BCR), creating a new health care industry leader with approximately $16 billion in annualized revenue. The ... Approach. Mergers and acquisitions (M&A) serve as an integral tool for BD in advancing its strategy of improving patient outcomes, reducing the cost of care, expanding access and enhancing the operations of our customers around the world. In recent years BD has completed dozens of tuck-in acquisitions including TVA Medical, Medafor, and Kiestra ... Becton Dickinson and Co (BD) is a medical technology company, which manufactures and sells medical devices, reagents, and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; pre-fillable drug delivery systems; respiratory ventilation and diagnostic equipment and ... BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.milestone for our company and a true testament to our history of innovation and leadership in healthcare. Our company was founded in 1897 when Maxwell Becton and Fairleigh Dickinson met by chance in a train station restaurant in Texas. Together, they forged a company with a strong set of values and a relentless focus on theAnalyst Report: Becton, Dickinson and Company Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and...Sep 6, 2023 · When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year. BD Pyxis™ IV Prep. Intercept errors, reduce waste and optimize IV workflows BD Pyxis™ IV Prep is a comprehensive, gravimetric-based IV workflow management system that helps deliver safe and efficient medication compounding. BD Pyxis™ MedBank™. MedBank solutions focus on automating medication inventory management processes to help ...BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo... As one of the largest global medical technology companies in the world, BD is deploying its capabilities, expertise and scale to address critical health needs related to coronavirus – from diagnostic offerings to identify COVID-19, to real-time informatics and electronic surveillance technology and to essential medical devices that support ... 概要. 1897年、Maxwell BectonとFairleigh S. Dickinsonによって設立された。. アメリカ合衆国ニュージャージー州フランクリンレイクスに統合本社を置く。. 2013年現在、世界50カ国以上に支社をもち [1] 、およそ30,000人の従業員を抱える。. 事業の対象となる顧客は ...Still can’t find what you’re looking for? Call us at: 1.844.8.BD.LIFE (844.823.5433) or Contact Us. Live Chat.WavelinQ™ EndoAVF System is designed to create an endovascular AV fistula (endoAVF) for hemodialysis access in patients who have chronic kidney disease and need dialysis, using a completely endovascular approach in vessels that are not traditionally used during open surgery. Patients must meet certain anatomical characteristics that support ...Sep 6, 2023 · When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year. * The BD Veritor™ System for Rapid Detection of SARS-CoV-2 is intended for the qualitative detection of SARS-CoV-2 nucleocapsid antigens in direct anterior nasal swabs from individuals who are either suspected of COVID-19 by their health care provider within the first five days of the onset of symptoms, or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 ...8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events.Becton, Dickinson and Company operates as a medical technology company. The Company offers solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease ... Tom Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company). Polen leads the $20 billion global medical technology company headquartered in Franklin Lakes, NJ, and works alongside 75,000+ BD associates who are making an impact and fulfilling the company’s purpose of advancing the world of health™.8/2/23 - Saving Time Changes Lives: Recognising the importance of end-to-end diagnostics in the sepsis care pathway. 6/2/23 - BD opens new €4 million R&D centre in Dublin, will invest additional €30 million in Enniscorthy manufacturing plant. Events. BD has strong research and development capabilities to fight many of the world's most intractable diseases. Founded in New York in 1897, the company is headquartered in Franklin Lake, New Jersey ...Tom Polen is the chairman, CEO and president of BD (Becton, Dickinson and Company). Polen leads the $20 billion global medical technology company headquartered in Franklin Lakes, NJ, and works alongside 75,000+ BD associates who are making an impact and fulfilling the company’s purpose of advancing the world of health™.Careers. BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. We lead in patient and healthcare worker safety, and technologies that enable medical research and clinical laboratories. Our innovative solutions help advance medical research and ... BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta.BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo...BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following healthcare conferences: 2023 Wells Fargo...Inclusion, Diversity & Equity. Our leadership is committed to making BD the best possible place for talented people to work by driving inclusion and diversity as a cultural and strategic imperative across the company. Our associates come from all backgrounds, races, ages, colors, creeds, religions, genders, and orientations, and we are better ...BD Pyxis™ IV Prep. Intercept errors, reduce waste and optimize IV workflows BD Pyxis™ IV Prep is a comprehensive, gravimetric-based IV workflow management system that helps deliver safe and efficient medication compounding. BD Pyxis™ MedBank™. MedBank solutions focus on automating medication inventory management processes to help ...Jul 18, 2022 · FRANKLIN LAKES, N.J., July 18, 2022 / PRNewswire / -- BD (Becton, Dickinson and Company) (NYSE: BDX) today announced it has completed the acquisition of Parata Systems. Parata advances BD's transformative solutions strategy by providing a portfolio of innovative pharmacy automation solutions that power a growing network of pharmacies to reduce ... Welcome to the world of BD. is our purpose. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. WavelinQ™ EndoAVF System is designed to create an endovascular AV fistula (endoAVF) for hemodialysis access in patients who have chronic kidney disease and need dialysis, using a completely endovascular approach in vessels that are not traditionally used during open surgery. Patients must meet certain anatomical characteristics that support ...BD - Worldwide. BD is a global medical technology company that is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD leads in patient and health care worker safety and the technologies that enable medical research and clinical laboratories. The company provides innovative solutions that help ...Unlock the full potential of the BD FACSymphony™ platform with the flexibility of spectral unmixing or compensation workflows. "BD Horizon RealYellow™ 586 (RY586) Reagents look like the best alternative for PE and will simplify panel design on conventional flow cytometers. They can also be an additional dye for spectral panel design.”.BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. BD helps customers enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care.Becton, Dickinson and Company operates as a medical technology company. The Company offers solutions that help advance medical research and genomics, enhance the diagnosis of infectious disease ... Becton, Dickinson and Company (“Petitioner”) filed a Petition requesting inter partes review of claims 18, 22, and 25 of U.S. Patent No. 8,328,762 B2 (“the ’762 patent”). Paper 3, (“Pet.”). B. Braun Melsungen AG (“Patent Owner”) filed a Preliminary Response contending that the Petition should be denied as to all challenged claims. SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected] automated medication dispensing system supporting centralized medication management. It helps clinicians safely and efficiently dispense the right medications, for the right patients at the right time. The BD Pyxis™ MedStation™ ES along with the BD Pyxis™ ES platform offers enterprise-wise medication management through integration with HIT systems.SEC Filings/Section 16 Alerts. Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. Unlock the full potential of the BD FACSymphony™ platform with the flexibility of spectral unmixing or compensation workflows. "BD Horizon RealYellow™ 586 (RY586) Reagents look like the best alternative for PE and will simplify panel design on conventional flow cytometers. They can also be an additional dye for spectral panel design.”. BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta.An automated medication dispensing system supporting centralized medication management. It helps clinicians safely and efficiently dispense the right medications, for the right patients at the right time. The BD Pyxis™ MedStation™ ES along with the BD Pyxis™ ES platform offers enterprise-wise medication management through integration with HIT systems. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive. Franklin Lakes, NJ 07417. About us. BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The...Press Releases Alerts. Annual Report Alerts. Annual Reports/Proxy Alerts. Questions for the Investor Relations department can be addressed to: 1-800-284-6845. [email protected]. BD. Attn: Investor Relations. 1 Becton Drive.Oct 4, 2010 · See Becton, Dickinson Co. v. Tyco Healthcare Group, LP, No. 02-1694 GMS, 2008 WL 4610220 at *4, 2008 U.S. Dist. LEXIS 82915 at *10 (D.Del. Oct. 14, 2008) (footnote omitted) (" JMOL Decision "). Tyco then appealed to this court, challenging the district court's interpretation of the asserted claims and the denial of its motions for JMOL and a ... Create a culture of more efficient microbiology testing. BD Life Sciences - Integrated Diagnostic Solutions maintains an extensive portfolio of microbiology solutions designed to make your laboratory run more efficiently and effectively. As integrated, end-to-end offerings, our solutions help enhance testing while streamlining. BD Announces Launch of a Mobile App in Canada to Support Reporting from the BD Veritor ™ Plus System for Rapid Antigen Testing. Learn more. Product Alerts – Medical device recalls and other notices. 1/27/23 - BD Awards Educational Grant for Point of Care Testing Pilot in Alberta.Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies. May 25, 2011 · The district court granted summary judgment of noninfringement of all asserted claims in the 164 and 745 patents. Therasense, Inc. v. Becton, Dickinson Co., 560 F.Supp.2d 835, 854, 880 (N.D.Cal. 2008). The district court also found nearly all of the asserted claims of the 745 patent invalid due to anticipation. Sep 6, 2023 · When was Becton, Dickinson and Company's most recent ex-dividend date? Becton, Dickinson and Company's most recent ex-dividend date was Thursday, June 8, 2023. Is Becton, Dickinson and Company's dividend growing? Over the past three years, the company's dividend has grown by an average of 4.33% per year. .